Mark J. Cayabyab, Ph.D. - Publications

Affiliations: 
2003 Harvard University, Cambridge, MA, United States 
Area:
Microbiology

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Bontempo A, Chirino A, Heidari A, Boparai S, Arora S, Ruiz S, Antonson SA, Kawai T, Cayabyab MJ. Assessment of SARS-CoV-2 entry in gingival epithelial cells expressing CD147. European Journal of Oral Sciences. e12906. PMID 36412995 DOI: 10.1111/eos.12906  0.346
2015 Xie E, Kotha A, Biaco T, Sedani N, Zou J, Stashenko P, Duncan MJ, Campos-Neto A, Cayabyab MJ. Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance. Plos One. 10: e0143422. PMID 26618634 DOI: 10.1371/Journal.Pone.0143422  0.398
2013 Cayabyab MJ, Qin L, Kashino SS, Izzo A, Campos-Neto A. An unbiased peptide-wide discovery approach to select Mycobacterium tuberculosis antigens that target CD8+ T cell response during infection. Vaccine. 31: 4834-40. PMID 23933335 DOI: 10.1016/j.vaccine.2013.07.077  0.316
2009 Cayabyab MJ, Korioth-Schmitz B, Sun Y, Carville A, Balachandran H, Miura A, Carlson KR, Buzby AP, Haynes BF, Jacobs WR, Letvin NL. Recombinant Mycobacterium bovis BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responses. Journal of Virology. 83: 5505-13. PMID 19297477 DOI: 10.1128/Jvi.02544-08  0.383
2007 Hovav AH, Panas MW, Rahman S, Sircar P, Gillard G, Cayabyab MJ, Letvin NL. Duration of antigen expression in vivo following DNA immunization modifies the magnitude, contraction, and secondary responses of CD8+ T lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 179: 6725-33. PMID 17982062 DOI: 10.4049/Jimmunol.179.10.6725  0.37
2007 Hovav AH, Panas MW, Osuna CE, Cayabyab MJ, Autissier P, Letvin NL. The impact of a boosting immunogen on the differentiation of secondary memory CD8+ T cells. Journal of Virology. 81: 12793-802. PMID 17881444 DOI: 10.1128/Jvi.01519-07  0.423
2007 Qin L, Greenland JR, Moriya C, Cayabyab MJ, Letvin NL. Effects of type I interferons on the adjuvant properties of plasmid granulocyte-macrophage colony-stimulating factor in vivo. Journal of Virology. 81: 10606-13. PMID 17652387 DOI: 10.1128/Jvi.01000-07  0.315
2007 Hovav AH, Cayabyab MJ, Panas MW, Santra S, Greenland J, Geiben R, Haynes BF, Jacobs WR, Letvin NL. Rapid memory CD8+ T-lymphocyte induction through priming with recombinant Mycobacterium smegmatis. Journal of Virology. 81: 74-83. PMID 17050608 DOI: 10.1128/Jvi.01269-06  0.49
2006 Yu JS, Peacock JW, Vanleeuwen S, Hsu T, Jacobs WR, Cayabyab MJ, Letvin NL, Frothingham R, Staats HF, Liao HX, Haynes BF. Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatis. Clinical and Vaccine Immunology : Cvi. 13: 1204-11. PMID 16943347 DOI: 10.1128/Cvi.00195-06  0.576
2006 Cayabyab MJ, Hovav AH, Hsu T, Krivulka GR, Lifton MA, Gorgone DA, Fennelly GJ, Haynes BF, Jacobs WR, Letvin NL. Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env. Journal of Virology. 80: 1645-52. PMID 16439521 DOI: 10.1128/Jvi.80.4.1645-1652.2006  0.503
2004 Song B, Cayabyab M, Phan N, Wang L, Axthelm MK, Letvin NL, Sodroski JG. Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease. Virology. 322: 168-81. PMID 15063126 DOI: 10.1016/J.Virol.2004.02.001  0.636
2004 Si Z, Gorry P, Babcock G, Owens CM, Cayabyab M, Phan N, Sodroski J. Envelope glycoprotein determinants of increased entry in a pathogenic simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) passaged in monkeys. Aids Research and Human Retroviruses. 20: 163-73. PMID 15018704 DOI: 10.1089/088922204773004888  0.616
2004 Cayabyab M, Rohne D, Pollakis G, Mische C, Messele T, Abebe A, Etemad-Moghadam B, Yang P, Henson S, Axthelm M, Goudsmit J, Letvin NL, Sodroski J. Rapid CD4+ T-lymphocyte depletion in rhesus monkeys infected with a simian-human immunodeficiency virus expressing the envelope glycoproteins of a primary dual-tropic Ethiopian Clade C HIV type 1 isolate. Aids Research and Human Retroviruses. 20: 27-40. PMID 15000696 DOI: 10.1089/088922204322749477  0.692
2002 Gorry PR, Taylor J, Holm GH, Mehle A, Morgan T, Cayabyab M, Farzan M, Wang H, Bell JE, Kunstman K, Moore JP, Wolinsky SM, Gabuzda D. Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate. Journal of Virology. 76: 6277-92. PMID 12021361 DOI: 10.1128/Jvi.76.12.6277-6292.2002  0.649
2002 Zhou N, Luo Z, Luo J, Fan X, Cayabyab M, Hiraoka M, Liu D, Han X, Pesavento J, Dong CZ, Wang Y, An J, Kaji H, Sodroski JG, Huang Z. Exploring the stereochemistry of CXCR4-peptide recognition and inhibiting HIV-1 entry with D-peptides derived from chemokines Journal of Biological Chemistry. 277: 17476-17485. PMID 11880384 DOI: 10.1074/Jbc.M202063200  0.534
2001 Si Z, Cayabyab M, Sodroski J. Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys. Journal of Virology. 75: 4208-18. PMID 11287570 DOI: 10.1128/Jvi.75.9.4208-4218.2001  0.604
2000 Cayabyab M, Hinuma S, Farzan M, Choe H, Fukusumi S, Kitada C, Nishizawa N, Hosoya M, Nishimura O, Messele T, Pollakis G, Goudsmit J, Fujino M, Sodroski J. Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry. Journal of Virology. 74: 11972-6. PMID 11090199 DOI: 10.1128/Jvi.74.24.11972-11976.2000  0.715
1999 Kolchinsky P, Mirzabekov T, Farzan M, Kiprilov E, Cayabyab M, Mooney LJ, Choe H, Sodroski J. Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication. Journal of Virology. 73: 8120-6. PMID 10482561 DOI: 10.1128/Jvi.73.10.8120-8126.1999  0.681
1999 Farzan M, Mirzabekov T, Kolchinsky P, Wyatt R, Cayabyab M, Gerard NP, Gerard C, Sodroski J, Choe H. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell. 96: 667-76. PMID 10089882 DOI: 10.1016/S0092-8674(00)80577-2  0.669
1999 Cayabyab M, Karlsson GB, Etemad-Moghadam BA, Hofmann W, Steenbeke T, Halloran M, Fanton JW, Axthelm MK, Letvin NL, Sodroski JG. Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2) Journal of Virology. 73: 976-984. PMID 9882298 DOI: 10.1128/Jvi.73.2.976-984.1999  0.652
1998 Choe H, Farzan M, Konkel M, Martin K, Sun Y, Marcon L, Cayabyab M, Berman M, Dorf ME, Gerard N, Gerard C, Sodroski J. The Orphan Seven-Transmembrane Receptor Apj Supports the Entry of Primary T-Cell-Line-Tropic and Dualtropic Human Immunodeficiency Virus Type 1 Journal of Virology. 72: 6113-6118. DOI: 10.1128/Jvi.72.7.6113-6118.1998  0.721
Show low-probability matches.